Beijing Business News (Reporter Zhao Boyu) May 27cryptostrategygamesAccording to the Weixin Official Accounts of "Yuce Biotech", Suzhou Yuce Biotech Co., Ltd.(hereinafter referred to as "Yuce Biotech") recently completed tens of millions of yuan in Pre-B+ round financing. This round of financing was exclusively invested by Pilot New Territories.
Public information shows that Yuce Biotech was established in 2019 and has a nearly 8000-square-meter R & D and production center. It is the industrialization of single molecule immune detection technology.cryptostrategygameshigh-tech companies. Since the beginning of 2024, Yuze Biotech has completed nearly 100 million yuan in continuous financing. After completing continuous financing, Yushi Biotech will continue to focus on neural markers, build a domestic new generation immune testing technology brand, and accelerate the market layout of early screening and early diagnosis of Alzheimer's disease.